InnoCare Pharma Limited (OTCMKTS:INCPF) Short Interest Update

InnoCare Pharma Limited (OTCMKTS:INCPF) was the target of a significant growth in short interest in August. As of August 14th, there was short interest totaling 124,000 shares, a growth of ∞ from the July 30th total of 0 shares. Based on an average daily volume of 0 shares, the short-interest ratio is currently ∞ days.

InnoCare Pharma Stock Performance

INCPF stock remained flat at $1.55 during midday trading on Friday. The stock’s fifty day moving average price is $1.55 and its 200-day moving average price is $1.58. InnoCare Pharma has a fifty-two week low of $1.55 and a fifty-two week high of $2.31.

Wall Street Analysts Forecast Growth

Separately, Morgan Stanley raised shares of InnoCare Pharma to an “overweight” rating in a research note on Thursday, May 28th. One equities research analyst has rated the stock with a Buy rating, According to data from MarketBeat, the stock has a consensus rating of “Buy”.

InnoCare Pharma Company Profile

InnoCare Pharma Ltd is a China-based, clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small-molecule targeted therapies for oncology. Headquartered in Shenzhen, Guangdong Province, the company leverages structure-based drug design and comprehensive preclinical screening to advance drug candidates that address high-unmet-need cancers.

The company’s development pipeline comprises multiple small-molecule inhibitors in various stages of preclinical and early clinical evaluation.